Natixis Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $393M | Buy |
1,561,703
+248,535
| +19% | +$53.5M | 0.44% | 38 |
|
|
2026
Q1 | $286M | Buy |
1,313,168
+8,278
| +0.6% | +$1.84M | 0.4% | 49 |
|
|
2025
Q4 | $298M | Buy |
1,304,890
+7,705
| +0.6% | +$1.76M | 0.42% | 35 |
|
|
2025
Q3 | $300M | Sell |
1,297,185
-4,569
| -0.4% | -$930K | 0.44% | 33 |
|
|
2025
Q2 | $242M | Buy |
1,301,754
+14,386
| +1% | +$2.67M | 0.38% | 45 |
|
|
2025
Q1 | $270M | Buy |
1,287,368
+89,518
| +7% | +$17.4M | 0.5% | 32 |
|
|
2024
Q4 | $213M | Sell |
1,197,850
-15,561
| -1% | -$2.86M | 0.4% | 46 |
|
|
2024
Q3 | $240M | Buy |
1,213,411
+60,157
| +5% | +$11.2M | 0.47% | 37 |
|
|
2024
Q2 | $198M | Buy |
1,153,254
+64,844
| +6% | +$10.7M | 0.43% | 41 |
|
|
2024
Q1 | $198M | Buy |
1,088,410
+91,985
| +9% | +$15.9M | 0.46% | 40 |
|
|
2023
Q4 | $154M | Buy |
996,425
+91,525
| +10% | +$13.3M | 0.41% | 47 |
|
|
2023
Q3 | $135M | Buy |
904,900
+273,282
| +43% | +$40.1M | 0.41% | 54 |
|
|
2023
Q2 | $85.1M | Sell |
631,618
-105,179
| -14% | -$15.4M | 0.26% | 90 |
|
|
2023
Q1 | $117M | Buy |
736,797
+58,125
| +9% | +$8.89M | 0.4% | 52 |
|
|
2022
Q4 | $110M | Buy |
678,672
+14,112
| +2% | +$2.16M | 0.41% | 55 |
|
|
2022
Q3 | $89.2M | Buy |
664,560
+88,312
| +15% | +$12.7M | 0.38% | 58 |
|
|
2022
Q2 | $88.3M | Sell |
576,248
-25,472
| -4% | -$3.89M | 0.39% | 57 |
|
|
2022
Q1 | $97.5M | Buy |
601,720
+74,571
| +14% | +$10.8M | 0.37% | 57 |
|
|
2021
Q4 | $71.4M | Buy |
527,149
+62,096
| +13% | +$7.34M | 0.27% | 83 |
|
|
2021
Q3 | $50.2M | Sell |
465,053
-6,687
| -1% | -$764K | 0.21% | 110 |
|
|
2021
Q2 | $53.1M | Buy |
471,740
+47,609
| +11% | +$5.36M | 0.25% | 94 |
|
|
2021
Q1 | $45.9M | Buy |
424,131
+42,342
| +11% | +$4.53M | 0.24% | 98 |
|
|
2020
Q4 | $40.9M | Sell |
381,789
-72,528
| -16% | -$6.97M | 0.24% | 103 |
|
|
2020
Q3 | $39.8M | Sell |
454,317
-163,891
| -27% | -$15.4M | 0.25% | 88 |
|
|
2020
Q2 | $60.7M | Buy |
618,208
+54,980
| +10% | +$4.84M | 0.4% | 50 |
|
|
2020
Q1 | $42.9M | Sell |
563,228
-139,441
| -20% | -$11.9M | 0.35% | 63 |
|
|
2019
Q4 | $62.2M | Buy |
702,669
+30,407
| +5% | +$2.52M | 0.44% | 47 |
|
|
2019
Q3 | $50.9M | Buy |
672,262
+98,891
| +17% | +$6.78M | 0.4% | 54 |
|
|
2019
Q2 | $41.7M | Buy |
573,371
+142,676
| +33% | +$11.2M | 0.34% | 67 |
|
|
2019
Q1 | $34.7M | Buy |
430,695
+4,428
| +1% | +$362K | 0.3% | 73 |
|
|
2018
Q4 | $39.3M | Buy |
426,267
+203,246
| +91% | +$17.9M | 0.39% | 54 |
|
|
2018
Q3 | $21.1M | Sell |
223,021
-16,684
| -7% | -$1.58M | 0.19% | 121 |
|
|
2018
Q2 | $22.2M | Sell |
239,705
-282
| -0.1% | -$27.5K | 0.21% | 102 |
|
|
2018
Q1 | $22.7M | Buy |
239,987
+3,968
| +2% | +$436K | 0.22% | 89 |
|
|
2017
Q4 | $22.8M | Sell |
236,019
-28,279
| -11% | -$2.67M | 0.23% | 90 |
|
|
2017
Q3 | $23.5M | Buy |
264,298
+1,522
| +0.6% | +$116K | 0.25% | 75 |
|
|
2017
Q2 | $19.1M | Sell |
262,776
-52,433
| -17% | -$3.52M | 0.21% | 101 |
|
|
2017
Q1 | $20.5M | Sell |
315,209
-5,723
| -2% | -$360K | 0.23% | 88 |
|
|
2016
Q4 | $20.1M | Buy |
320,932
+76
| +0% | +$4.64K | 0.24% | 89 |
|
|
2016
Q3 | $20.2M | Buy |
320,856
+14,107
| +5% | +$913K | 0.26% | 80 |
|
|
2016
Q2 | $19M | Sell |
306,749
-23,297
| -7% | -$1.42M | 0.26% | 86 |
|
|
2016
Q1 | $18.9M | Buy |
330,046
+182,413
| +124% | +$10.2M | 0.28% | 69 |
|
|
2015
Q4 | $8.75M | Sell |
147,633
-1,158
| -0.8% | -$66.7K | 0.14% | 183 |
|
|
2015
Q3 | $8.1M | Buy |
148,791
+7,599
| +5% | +$495K | 0.14% | 185 |
|
|
2015
Q2 | $9.49M | Buy |
141,192
+23,451
| +20% | +$1.53M | 0.16% | 166 |
|
|
2015
Q1 | $6.89M | Buy |
117,741
+19,757
| +20% | +$1.19M | 0.12% | 245 |
|
|
2014
Q4 | $6.41M | Buy |
97,984
+4,795
| +5% | +$302K | 0.12% | 252 |
|
|
2014
Q3 | $5.38M | Sell |
93,189
-5,695
| -6% | -$316K | 0.11% | 286 |
|
|
2014
Q2 | $5.58M | Buy |
98,884
+10,564
| +12% | +$554K | 0.08% | 402 |
|
|
2014
Q1 | $4.54M | Sell |
88,320
-5,572
| -6% | -$282K | 0.07% | 441 |
|
|
2013
Q4 | $4.96M | Buy |
93,892
+4,422
| +5% | +$217K | 0.08% | 393 |
|
|
2013
Q3 | $4M | Buy |
89,470
+7,421
| +9% | +$329K | 0.07% | 420 |
|
|
2013
Q2 | $3.39M | Buy |
+82,049
| New | +$3.59M | 0.07% | 447 |
|
Other funds holding ABBV
Natixis Advisors's ABBV Position: Q2 2026 in Review
Natixis Advisors increased its AbbVie (ABBV) stake by 19% in Q2 2026, buying an estimated $53.5M and bringing the position to 1,561,703 shares worth $393M. The position accounts for 0.44% of the portfolio, ranked #38.
Natixis Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Natixis Advisors held 1,561,703 shares of AbbVie worth $393M as of Q2 2026.
- Natixis Advisors bought 248,535 AbbVie shares in Q2 2026, an estimated $53.5M.
- AbbVie made up 0.44% of Natixis Advisors's portfolio in Q2 2026, its #38 holding.
- Natixis Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.